TP53 and neoplasm: The p533KR/3KR mutant fail to induce p53-mediated cell cycle arrest, apoptotic cell death and senescence in response to DNA damage, yet still retains tumor suppression capacities, providing a unique tool to dissect the mechanisms of p53-mediated activities in vivo [10].